| 1 |
35366939 | Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers. | 2022 Apr 2 |
1 |
| 2 |
33545279 | Pulmonary administration of a CSF-1R inhibitor alters the balance of tumor-associated macrophages and supports first-line chemotherapy in a lung cancer model. | 2021 Apr 1 |
1 |
| 3 |
33805444 | Withholding of M-CSF Supplement Reprograms Macrophages to M2-Like via Endogenous CSF-1 Activation. | 2021 Mar 29 |
1 |
| 4 |
34288020 | IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1. | 2021 Dec |
1 |
| 5 |
34969774 | Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer. | 2021 Dec |
2 |
| 6 |
32787110 | Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1R. | 2020 Sep 10 |
1 |
| 7 |
30616794 | Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy. | 2019 Jan |
2 |
| 8 |
29875321 | Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy. | 2018 Jun 7 |
1 |
| 9 |
29059867 | Spatial targeting of tumor-associated macrophage and tumor cells with a designer nanocarrier for cancer chemo-immunotherapy. | 2017 Jul |
1 |
| 10 |
28101209 | Significance of interstitial tumor-associated macrophages in the progression of lung adenocarcinoma. | 2016 Dec |
1 |